Finance Watch: Ascendis Spins Out Ophthalmology Firm Eyconis With $150m
New Company Will Use TransCon For Eye Diseases
Private Company Edition: Publicly held Ascendis outsourced its preclinical AMD program to private Eyconis. Also, Innovation Endeavors revealed a new $630m VC fund and Mirae raised $50m for its first life science fund, while Accent, Comanche and Tr1X each brought in $75m rounds.
